Showing results (151-160 of 373) with videos related to

Sort By:
Pageof 38
Human Pathology|June 21, 2006
High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesisTae-Joong Kim, Seung Bae Rho, Yoon-La Choi, et al.
International Immunology|September 8, 2004
T cell expression of CIITA represses Th1 immunityWeon Seo Park, Youngmee Bae, Doo Hyun Chung, et al.
Anticancer Research|February 11, 2014
Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapyHong Kwan Kim, Ho Yun Lee, Yoon-La Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2020
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational StatusJiyun Lee, Yoon La Choi, Joungho Han, et al.
Cancer Research and Treatment|February 7, 2017
Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean PatientsMi-Sook Lee, Eun Ah Jung, Sung Bin An, et al.
Cancer Chemotherapy and Pharmacology|December 4, 2009
Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor statusYeon Hee Park, Soohyeon Lee, Eun Yoon Cho, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 22, 2004
An immunohistochemical study of the expression of adhesion molecules in gallbladder lesionsYoon-La Choi, Yan Hua Xuan, Young Kee Shin, et al.
Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.
Head & Neck|July 13, 2011
Identification of a cut-off for the MACIS score to predict the prognosis of differentiated thyroid carcinoma in children and young adultsHye Won Jang, Ji In Lee, Hee Kyung Kim, et al.
Breast Cancer Research and Treatment|January 25, 2012
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy?Yeon Hee Park, Seock-Ah Im, Eun Yoon Cho, et al.
Pageof 38